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 2 
New Findings 24 
We review the influence of prematurity on the cardiorespiratory system and examine the 25 
common sequel of alterations in oxygen tension, and immune activation in preterm infants. 26 
We explore the neonatal animal models of hypoxia, hyperoxia and infection that contribute 27 
to our understanding of stress on neurodevelopment and cardiorespiratory homeostasis. 28 
Finally, we highlight some of the important physiological pathways that have a modulatory 29 
role on the cardiorespiratory system in early life. 30 
 31 
Abstract 32 
Preterm birth is one of the leading causes of neonatal mortality. Babies that survive early 33 
life stress associated with immaturity, have significant prevailing short- and long-term 34 
morbidities. Oxygen dysregulation in the first few days and weeks after birth is a primary 35 
concern as the cardiorespiratory system slowly adjusts to extra-uterine life. Infants exposed 36 
to rapid alterations in oxygen tension, including exposures to hypoxia and hyperoxia, have 37 
altered redox balance and active immune signalling leading to altered stress responses that 38 
impinge on neurodevelopment and cardiorespiratory homeostasis. In this review, we 39 
explore the clinical challenges posed by preterm birth followed by an examination of the 40 
literature on animal models of oxygen dysregulation and immune activation in the context 41 
of early life stress.  42 
 3 
Introduction 43 
Preterm birth is the leading cause of infant death worldwide (Lawn and Kinney, 2014). The 44 
rate of preterm birth is approximately 6-12% in USA and Europe, and some common risk 45 
factors include increasing maternal age, assistive reproductive techniques, multiple birth and 46 
obstetrical interventions in the form of Caesarean sections (Lantos and Lauderdale, 2011, 47 
Institute of Medicine Committee on Understanding Premature and Assuring Healthy, 2007, 48 
Frey and Klebanoff, 2016). Testament to improved obstetric and neonatal care, survival of 49 
preterm infants born after 22 weeks of gestational age has risen dramatically in the 21st 50 
century and continues to do so in recent years (Santhakumaran et al., 2018). The improved 51 
survival rates of this immature population bring about new uncertainties and provide new 52 
impetus to address ongoing clinical questions and treatment strategies in terms of early life 53 
stress. The growth in observational and interventional clinical research studies in the preterm 54 
population, supported by improved translational preclinical animal models, have contributed 55 
to a wealth of knowledge, awareness and improved evidence-based practice. Examples of 56 
improved clinical practice include antenatal steroid use, delayed cord clamping, surfactant 57 
administration, targeted oxygen saturation limits and titrated oxygen use. Yet significant 58 
challenges remain, to improve both survival and the quality of life of  the smallest of preterm 59 
infants (Manuck et al., 2016). In this review, we discuss cardiorespiratory complications 60 
arising from preterm birth that lead to oxygen dysregulation. We explore increased 61 
vulnerability associated with variable patterns of early life oxygen insufficiency, as revealed 62 
by animal models of oxygen dysregulation. We examine the interplay between oxygen 63 
insufficiency and subsequent immune activation and putative mechanisms underpinning 64 
interactions between these physiological stressors. Finally, we will highlight gaps in the 65 
literature regarding gram-positive immune activation and the study of intrinsic sex 66 
differences in response to early life stress.  67 
 68 
Preterm Physiology 69 
Preterm birth is a primary risk factor for infant morbidity (e.g. respiratory infection and 70 
bronchopulmonary dysplasia (BPD)) and long-term disability (e.g. cerebral palsy, sensory and 71 
cognitive deficits) worldwide with huge emotional and financial costs (Frey and Klebanoff, 72 
2016, O'Shea et al., 2009). While it is true that those born the earliest are at greater risk of 73 
adverse outcomes, babies born late preterm still have significant difficulty, with 74 
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approximately one third of these infants requiring intensive care (McIntire and Leveno, 2008), 75 
rehospitalisation in early childhood (Colin et al., 2010) and long-term respiratory deficits 76 
(Kotecha and Kotecha, 2012, Kotecha et al., 2012). Preterm infants face numerous challenges 77 
due to their anatomical and physiological immaturity, such as under-developed lungs and 78 
defence mechanisms (e.g. antioxidants), immature sensory networks, poor respiratory and 79 
upper airway motor co-ordination, immature myocardial function and persistent patent 80 
ductus arteriosus (Figure 1). Birth normally triggers a rapid sequence of physiological 81 
adaptations to sustain life outside of the uterus, inflating the lungs to oxygenate the blood 82 
and establish a new homeostatic environment (Hillman et al., 2012). However, preterm birth 83 
interrupts normal neurodevelopmental processes that are temporally programmed. 84 
Consequently, the first steps toward independence are often burdened with complications 85 
and failure to establish an efficient cardio-respiratory system. Many preterm infants will 86 
present with signs, such as, grunting, nasal flaring, tachypnoea and chest retractions that 87 
require immediate management and are indicators of respiratory insufficiency such as 88 
surfactant deficiency, airway obstruction and diaphragm dysfunction or non-respiratory 89 
conditions such as sepsis. We will briefly outline some of the cardiorespiratory challenges of 90 
the preterm transition. 91 
 92 
Cardiorespiratory function in preterm infants 93 
Lung development begins early in the embryonic phase, however it does not reach the end 94 
phase (alveolar) until after 37 weeks of gestational age (GA) at which time there is increased 95 
surface area and density of mature Type II pneumocytes producing surfactant (Reuter et al., 96 
2014). Infants born preterm (i.e. <37 weeks’ GA) often have fluid on the lung in addition to 97 
greater surface tension within the lungs, higher pulmonary dead space (VD) and VD: tidal 98 
volume ratio leading to increased collapsibility and decreased area for efficient gas exchange 99 
(Ghafoor et al., 2003, Dassios et al., 2015, Dassios et al., 2017, Helve et al., 2007, Helve et al., 100 
2004, Janer et al., 2010). The most immature infants will have the least developed lung 101 
structures. Some research suggests that preterm birth can arrest development meaning that 102 
infants have blunted lung growth and smaller pulmonary surface area, though this may be 103 
related to respiratory complications of bronchopulmonary dysplasia (Greenough et al., 2005, 104 
May et al., 2011, Margraf et al., 1991). The chest wall of the preterm infant has a poorly 105 
developed collagen matrix, which contributes to reduced outward recoil of the chest wall and 106 
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increased tendency for the lungs to collapse. Preterm infants generally maintain their lung 107 
volume above resting functional residual capacity and prevent atelectasis by maintaining a 108 
high respiratory rate, laryngeal adduction during exhalation to increase the resistance to 109 
airflow, diaphragmatic muscle tone during expiration and reducing the expiratory time (Stark 110 
et al., 1987). The diaphragm is the main inspiratory pump muscle and works particularly hard 111 
in preterm infants while accessory muscles such as the external intercostal muscles work 112 
primarily to stabilise the thoracic cavity rather than increase tidal volume. The inspiratory 113 
muscles of preterm infants are composed of fewer slow oxidative myosin heavy chain (MHC) 114 
type 1 fibres compared with their term counterparts making the former more susceptible to 115 
fatigue when loaded (Sieck et al., 1991). A similar developmental profile is apparent in 116 
neonatal rodents (O'Connell et al., 2013).  117 
 118 
Infants are primarily nasal breathers with high inter-breath variability especially in the 119 
preterm, indicative of their poor respiratory control and collapsible upper airway structures 120 
(Pandit et al., 2000, Beck et al., 2011, Duara et al., 1991, Gauda et al., 1987). This leaves the 121 
preterm infant vulnerable to both central and obstructive apnoeas that are commonly 122 
reported (Lemke et al., 1998, Upton et al., 1992, Fairchild et al., 2016). Apnoeas in preterm 123 
infants can be profound as a result of their low respiratory reserve capacity, giving rise to 124 
bradycardia, temporary absence of reflexes coupled with their high metabolic demands (Fyfe 125 
et al., 2014, Gerhardt and Bancalari, 1984). Apnoeas are commonly preceded by periods of 126 
hypoventilation (Adams et al., 1997, al-Saedi et al., 1997, Poets and Southall, 1991). Though 127 
the carotid body is likely anatomically mature at birth (Hervonen and Korkala, 1972), it takes 128 
time for the preterm to establish hypoxic and CO2 thresholds after  birth, usually occurring 129 
over a period of hours-to-days of life (Williams et al., 1991, Darnall, 2010) but this may be 130 
delayed in infants with recurrent apnoea (Katz-Salamon, 2004). The poor control of breathing 131 
is most evident during feeding, which requires a co-ordinated suck-swallow-breath 132 
mechanism. There is evidence of increased apnoeic episodes during feeding in infants born 133 
preterm (Thoyre and Carlson, 2003), which may be potentiated in bottle-fed babies as a result 134 
of increased vacuum with sucking (Jenik et al., 2012). In addition, increased respiratory muscle 135 
activation has been observed during feeding desaturation in preterm infants compared to 136 
term infants indicating an increased work-of-breathing and thoraco-abdominal asynchrony 137 
that will likely contribute to respiratory fatigue (Kwon et al., 2018). Overall, immature lung 138 
 6 
and skeletal muscle form along with poor neural control contribute to poor ventilation in the 139 
preterm infant. 140 
 141 
The respiratory system works in tandem with the cardiovascular system. Adequate oxygen 142 
transport and delivery is dependent on an efficient cardiovascular system and ability to carry 143 
and offload oxygen where it is required. After birth, cord clamping is a necessary intervention, 144 
though the timing is important. Delayed cord clamping, for at least 1 minute after birth, is 145 
essential to ensure sufficient transfer of placental blood to the baby increasing its blood 146 
volume and stabilising the cardiorespiratory system, in turn minimising need for transfusions 147 
(McAdams et al., 2018, Ersdal et al., 2016, Ersdal et al., 2014, Finn et al., 2019). In the preterm 148 
infant, adult haemoglobin will be at lower concentration than term infants, with preterm 149 
infants still circulating fetal haemoglobin. Preterm neonates have oxyhaemoglobin 150 
dissociation curves that are severely shifted to the right making these infants prone to severe 151 
hypoxia with minor drops in the provided FiO2 (Dassios et al., 2015). Anaemia is common in 152 
preterm infants due to phlebotomy losses, breakdown of fetal haemoglobin and an immature 153 
haemopoietic system, for example low production of erythropoietin, and blood transfusions 154 
to reverse anaemia are necessary to prevent hypoxia (Bishara and Ohls, 2009, Saito-Benz et 155 
al., 2018, Whitehead et al., 2018). The physiological transition from fetal circulation to the 156 
post-natal circulation requires a complex series of events to divert blood flow from the right 157 
ventricle of the heart to the lungs and minimise shunts to the systemic circulation via the 158 
foramen ovale and the ductus arteriosus. At this time, adequate oxygen delivery to the lungs 159 
is important to prevent shunting in the pulmonary system, raising right ventricular afterload. 160 
The structural formation of blood vessels, particularly capillaries in preterm brains are weak 161 
and can easily rupture. Weak blood vessels and immature structural network can contribute 162 
to serious acute trauma of metabolically active neural tissue such as intraventricular 163 
haemorrhage and periventricular leukomalacia (Ballabh, 2010, Ballabh et al., 2004, Volpe, 164 
2009). 165 
 166 
Clinical approaches to preterm respiratory care 167 
Treatment strategies have been revised over the years to maximise therapeutic value while 168 
limiting associated risks that compound the problems faced by preterm infants (Stoll et al 169 
2015). As a result of both the immature anatomy and physiology, preterm infants often 170 
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struggle to inflate their lungs following delivery and in that situation neonatologists intervene 171 
within the first minutes to stabilise (Wyckoff et al., 2015, Kilmartin et al., 2018). Neonatal 172 
resuscitation has been reviewed elsewhere by Roehr and Bohlin (2011) who highlight that 173 
CPAP and early surfactant administration have been demonstrated to be a safe and effective 174 
strategy for resuscitation. Yet many unanswered questions remain in the immediate 175 
management: how much oxygen to give, how much pressure to use and how best should it 176 
be delivered? Despite significant research to date, the optimal protocol for oxygen 177 
supplementation during resuscitation of preterm infants remains to be determined (Lara-178 
Canton et al., 2019). In recent years, neonatologists have moved from resuscitation with 179 
supplemental oxygen to resuscitation in room air and titrating supplemental oxygen over the 180 
next few minutes in an effort to reduce the oxidative and inflammatory burden caused by 181 
hyperoxia (Vento et al., 2009, Kapadia et al., 2017, Lui et al., 2018). The initial period after 182 
birth has been termed the ‘golden hour’ and implementation of the revised Golden Hour 183 
process, which encourages use of standardised evidence-based approaches and collaboration 184 
has had positive implications for preterm outcomes (Reynolds et al., 2009, Sharma, 2017). 185 
Although these practices are implemented widely, adherence could be improved (Shah et al., 186 
2018).  187 
 188 
After delivery room resuscitation, a significant proportion of preterm infants require on-going 189 
respiratory support in the NICU (Fairchild et al., 2016). Methods of respiratory support have 190 
evolved to limit the incidence of long-term lung disease such as BPD (Fischer and Bührer, 191 
2013, Subramaniam et al., 2016). Steroid use postnatally has not been as successful as 192 
antenatal treatment in the maturation of the lung and prevention of disease and therefore 193 
postnatal administration is no longer recommended routinely due to the many long-term 194 
adverse effects of the drug (Halliday, 2017). Non-invasive ventilation such as continuous 195 
positive airway pressure (CPAP), Bilevel Positive Airway Pressure (BiPAP), high-frequency 196 
oscillatory ventilation, volume targeted ventilation (VTV) and high-flow nasal cannula have 197 
been successful in limiting damage of the airways; yet more studies are needed to directly 198 
compare different support systems to determine the best device for provision of respiratory 199 
support during preterm development and in the prevention of extubation failure (Cummings 200 
and Polin, 2016, Roberts and Hodgson, 2017, Manley et al., 2013, Victor et al., 2016, Rong et 201 
al., 2016, Zhu et al., 2017, Klingenberg et al., 2017). The preterm infant’s respiratory function 202 
 8 
and nutritional status are interlinked. Feeding intolerance can limit the energy necessary for 203 
growth and repair and is discussed in reviews by (Bozzetti et al., 2017, Su, 2014). A multicentre 204 
randomized single-blind controlled trial called ENTARES is currently underway to examine the 205 
impact of nasal continuous positive airway pressure and heated humidified high-flow nasal 206 
cannula on enteral nutrition (Cresi et al., 2019). 207 
 208 
Oxygen supplementation in the most commonly used therapy in the NICU, yet the optimal 209 
oxygen targets in extremely preterm infants are not well defined. Supplemental oxygen 210 
clearly plays an important role in maintaining adequate oxygenation, reported to decrease 211 
apnoeic events, offset the severity of desaturation associated with apnoea and lessen the 212 
number of serious life-threatening events in preterm infants (Samuels et al 1994, Sekar and 213 
Duke 1991, Watkin et al 1996). The NEoProm meta-analysis study recruited nearly 5000 214 
extremely preterm infants and set out to compare the impact of targeting differential oxygen 215 
status (SpO2 85-89% versus 91-95%) on the primary outcome measure of composite death or 216 
major disability in these infants at 18-24 months. The study reported no difference in its 217 
primary outcomes, yet reported that the lower SpO2 target range was associated with higher 218 
risk of death and necrotising enterocolitis, but a lower risk of retinopathy of prematurity 219 
(Zahari et al., 2016, Askie et al., 2017, Askie et al., 2018, Schmidt et al., 2013, Schmidt et al., 220 
2016). At the moment, based on the evidence available, SpO2 should be targeted at the higher 221 
level of 91-95% and should not be exceeded (Bizzarro, 2018, Deschmann and Norman, 2017, 222 
STOPROP, 2000). Retinopathy of prematurity is one of the major clinical side effects of 223 
supplemental oxygen therapy, but in some cases it is viewed as a necessary risk given the 224 
long-term benefits of maintaining adequate oxygenation. Yet, the danger of both hypoxia and 225 
hyperoxia means neonatologists and their vulnerable patients are walking a fine line since 226 
both stressors can induce fundamental cellular and molecular changes that are not easily 227 
observed clinically in the acute setting but have potential for long-lasting deleterious 228 
outcomes.  We will discuss the impact of variable patterns of hypoxia and hyperoxia on 229 
cardiorespiratory physiology in the context of animal models in later sections. 230 
 231 
Not only is it unclear how much oxygen should be delivered, the method of measuring oxygen 232 
sufficiency remains a challenge. The introduction of non-invasive oxygen saturation 233 
measurement in 1980’s has been a welcome addition to neonatal care but it is not perfect 234 
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(Sola et al., 2005). Some causes for concern with the increased reliance on this method is the 235 
possibility of ‘missed’ oxygen desaturations as a result of a) varied algorithms used by 236 
different manufacturers that can often average data over periods of 10s, missing short 237 
apnoeas, b) saturation may appear normal despite anaemia, and c) habituation of care staff 238 
to alarms mean that they often disregard or mute alarms without action. Risks of inadvertent 239 
hyperoxia also exist and are not detectable using SpO2 measurements due to the very nature 240 
of the oxygen dissociation curve, wherein large changes in partial pressure of oxygen (PO2) 241 
above 100mmHg are not detectable since haemoglobin is fully saturated. Anderson et al. 242 
(2017) published a detailed review on ‘adequate oxygenation’ highlighting that current 243 
monitoring and interventions target oxygen delivery (inspired oxygen, oxygen saturation, 244 
oxygen carrying capacity and blood flow), but do not consider oxygen consumption. The 245 
authors along with other groups (Tataranno et al., 2015, Kenosi et al., 2014, Kenosi et al., 246 
2018, Kenosi et al., 2015) recommend additional studies to test the use of cutaneous oxygen 247 
saturation combined with NIRS measurement of tissue oxygen saturation to determine a 248 
reference value for oxygen adequacy and as a useful tool for early identification of vulnerable 249 
infants based on brain metabolism (Garvey et al., 2018).  250 
 251 
Preterm infants are at high risk of respiratory conditions such as apnoea of prematurity (AOP), 252 
respiratory distress syndrome (RDS) and BPD in addition to respiratory infection, wheezing 253 
hospital re-admission and decreased exercise capacity (Haataja et al., 2016, Paranjothy et al., 254 
2013, Haataja et al., 2018, Leps et al., 2018, Farrell et al., 2015). Oxygen dysregulation is 255 
associated with developmental impairments in childhood. Di Fiore et al., (2019) reported that 256 
preterm infants with increased oxygen and frequent intermittent hypoxia (IH) events during 257 
just the first 3 days of age were commonly on asthma medication at 2 years and total apnoea 258 
days were associated with neurodevelopment impairments (Janvier et al., 2004). Raffay et al., 259 
(2019) reported an association between frequent, longer, and less severe IH events as well as 260 
oxygen supplementation and respiratory pressure support within the first 26 days of life and 261 
incidence of BPD at 36 weeks’ postmenstrual age. There is growing evidence to suggest sex-262 
specific developmental trajectory and thereby sex-dependent responses to treatment and 263 
long-term outcomes, with male sex recognised as a significant factor in poor respiratory 264 
outcomes in preterm infants (Wiswell et al., 1990, Farrell and Wood, 1976). Males are 265 
reported to require prolonged respiratory support and increased evidence of airway 266 
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obstruction compared to females (Bairam et al., 2018, Bentsen et al., 2017). A recent review 267 
by Kotecha et al., (2018) summarises the evidence for increased risk of male sex on adverse 268 
respiratory outcomes in preterm infants. Sex has often been excluded as a factor in the 269 
analysis of clinical data and often disregarded in preclinical data with most studies either 270 
focusing on males exclusively, or not sexing animals at all. There is increased focus on sexual 271 
dimorphism particularly in relation to developmental stress. The importance of studying both 272 
sexes is now more widely recognised revealing greater physiological insights into stress 273 
responses and recovery mechanisms. 274 
 275 
In summary, establishing and maintaining adequate oxygenation in preterm infants remains 276 
one of the major responsibilities and challenges within neonatal intensive care units. Efforts 277 
are made to facilitate efficient gas exchange across the alveoli, adequate perfusion of the 278 
lungs and appropriate delivery of oxygen to tissues where it is required whilst minimising 279 
potential iatrogenic harm. It is imperative that we strive to understand the impact of oxygen 280 
dysregulation on cardio-respiratory development and the impact that oxygen dysregulation 281 
has on vulnerability in both male and female preterm infants, with the aim of developing 282 
targeted therapies. In addition, despite progress, much work remains to gather contemporary 283 
normative data across the range of preterm ages, to optimise timing, delivery and withdrawal 284 
of treatments as well as identification of infants particularly ‘at risk’. Novel preventative 285 
strategies need to be identified to support cardiorespiratory stability in the NICU, offsetting 286 
potential stressors. Much of the normative data currently in use was gathered in an era 287 
without the use of prenatal corticosteroid administration, continuous positive airway 288 
pressure, exogenous surfactant replacement, refinements in the use of supplemental oxygen, 289 
and a return to delayed cord clamping. Long-term retrospective and prospective studies of 290 
the current spectrum of preterm survivors also need to be conducted to fully assess the 291 
persistence of respiratory disease in the preterm population in the context of modern 292 
therapeutic approaches. 293 
 294 
Animal models of postnatal stress 295 
Postnatal stressors 296 
Anatomical and physiological immaturity can present life-threatening stressors in the preterm 297 
infant such as hypoxia, acidosis, hypoglycaemia, and cold stress. Additionally, preterm infants 298 
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are exposed to multiple iatrogenic stressors owing to the negative side effects of therapeutic 299 
strategies (e.g. hyperoxia, volutrauma, barotrauma and painful procedures) and/or the 300 
hospital environment (e.g. nosocomial infection via compromised immune barrier, bright 301 
lights and noise). Physiological stressors are stimuli that challenge homeostasis and typically 302 
activate sensory receptors, which initiate adaptive responses. As we have learned, the 303 
respiratory system of the preterm infant is not fully developed until the end of gestation and 304 
even at this point the circuitry is plastic, with sensory inputs undergoing a period of resetting, 305 
with continued maturation of the neuromechanical breathing network based on sensory 306 
feedback. Psychological stressors such as parental separation mainly activate cortical and 307 
limbic circuits but can also elicit visceral responses. A large amount of work has been carried 308 
out in models of altered maternal-offspring interaction particularly examining dysfunction of 309 
higher brain functions such as cognition, memory and learning and affective disorders such 310 
as anxiety and depression (Aisa et al., 2007, Bolton et al., 2017, Jin et al., 2018, Francis et al., 311 
1999). However, there is also a growing body of literature on cardio-respiratory function in 312 
animal models of dysfunctional maternal-offspring interaction building on the early work by 313 
Hofer (1970), with recent publications continuing to support the significant physiological 314 
impact of maternal separation (Genest et al., 2007, Kinkead et al., 2005, Kinkead et al., 2009). 315 
As highlighted by Kovacs et al (2005), physiological and psychological stressors are not 316 
mutually exclusive and should be viewed in their complexity, relevant to both the clinical 317 
setting and those stressors used experimentally.  318 
 319 
Stressors such as hypoxia, hyperoxia and inflammation impact physiological function 320 
depending on the timing, pattern (acute/chronic), and severity/intensity of stimulus as well 321 
as the developmental age (critical windows) at which the stimulus is encountered and the 322 
intrinsic make-up of the individual, such as sex. Stressors may act independently through 323 
distinct pathways or interact in a hyper- or hypo-additive manner through 324 
priming/sensitisation, or preconditioning/desensitisation by means of convergence on 325 
common end pathways such as the hypothalamic pituitary adrenal axis (HPA), autonomic 326 
nervous system, immune activation or redox modulation. The hypothalamic pituitary adrenal 327 
(HPA) axis acts to maintain homeostasis by regulating metabolism including the immune 328 
response and mitochondrial function (Kasahara and Inoue, 2015). Ascending neurons from 329 
the nTS to the corticotrophin releasing hormone (CRH) and arginine vasopressin (AVP) 330 
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producing cells of the PVN in the hypothalamus mediate the neuroendocrine response i.e. 331 
the release of glucocorticoids (cortisol in humans, cortisone in rodents) along the HPA axis. 332 
Cortisol is released into the circulation from the adrenal glands, however the majority in 333 
circulation becomes bound to corticosteroid-binding globulin (CBG or transcortin) and is not 334 
biologically active. 335 
A stress hyporesponsive period is evident in rats from post-natal (P)3-P14, with evidence of 336 
blunted release of the ‘stress’ hormone corticosterone, in response to a mild stressor 337 
(Rosenfeld et al., 1996, Levine, 2001). This period of development in rats is similar to the 338 
development period of 20-40 weeks’ gestational age in humans (Clancy et al., 2001). Humans 339 
are suggested to be hyporesponsive to stress in the first year and perhaps extending 340 
throughout childhood (Gunnar and Quevedo, 2007, Gunnar and Fisher, 2006). However, 341 
during this stress hyporesponsive period the ability to respond to significantly stressful events 342 
remains. Stressors can induce acute responses and/or persistent long-term adaptations that 343 
are mediated through neuronal plasticity, eliciting persistent changes in neuronal 344 
connectivity and/or activity. Perinatal programming is the term used for the long-lasting 345 
impact of environmental stressors experienced either in utero or during neonatal life. These 346 
effects may persist throughout life and may even be transgenerational through epigenetic 347 
mechanisms (Khalyfa et al., 2017, Nanduri et al., 2017a, Nanduri et al., 2018, Nanduri and 348 
Prabhakar, 2013, Nanduri et al., 2017b). Many adult disorders should be viewed as beginning 349 
in early life and could be reduced by interventions that build resilience, decrease exposure to 350 
adversity and therapies that promote recovery (Shonkoff et al., 2009) .  351 
 352 
Animal models of early life oxygen dysregulation/stress have clearly demonstrated long-353 
lasting alterations in cardio-respiratory function (Mayer et al., 2013, Mayer et al., 2014, 354 
Stryker et al., 2018, Reeves and Gozal, 2006, Soukhova-O'Hare et al., 2008), as well as memory 355 
and sensorimotor deficits as a result of neural impairments (Juliano et al., 2015, Goussakov 356 
et al., 2019). Exploring stress responses during early life and (mal)adapatations to prevalent 357 
stressors will contribute to our understanding of vulnerability and resilience developed in 358 
preterm infants. Some of the key changes observed in response to early life stressors prioritise 359 
short-term survival and implement adaptations for the prevailing environmental conditions, 360 
albeit at the expense of other important but energy costing developments and as such can 361 
cause aberrant changes awry from the normal developmental trajectory. Another possibility 362 
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is that developmental damage to tissues with important functional roles gives rise to 363 
dysfunctional circuits and behaviours expressed in the long-term.  Herein, we review some of 364 
the recent data on cardiorespiratory function in animal models of neonatal oxygen 365 
dysregulation and then examine possible interactions with the immune system. 366 
 367 
Hypoxic response in the newborn 368 
Certain cell types are exquisitely sensitive to changes in PO2 and can initiate fast adaptive 369 
responses to a hypoxic stimulus; these are known as oxygen sensors. The glomus cells of the 370 
carotid body are established as the primary PO2 sensors ideally located at the carotid 371 
bifurcation, they send afferent signals via the carotid sinus nerve, a branch of the 372 
glossopharyngeal nerve, into the central respiratory control network. Other candidate sites 373 
have been put forward as oxygen sensors such central astrocytes (Funk and Gourine, 2018, 374 
Czeisler et al., 2019), unidentified cells of the spinal cord (Wilson et al., 2015), as well as 375 
centrally acting AMP-activated protein kinase (AMPK) (Evans et al., 2016). The hypoxic 376 
ventilatory response in new-born infants and mammals is biphasic; characterised by a short 377 
rise in minute ventilation followed by hypoxic ventilatory depression (Bissonnette, 2000). 378 
Adrenal chromaffin cells in neonates are also particularly sensitive to hypoxia; until the 379 
maturation of splanchnic innervation, these cells release catecholamines upon stimulation 380 
(Salman et al., 2014). The new-born rat often responds to hypoxia by decreasing metabolism 381 
(Mortola, 1993, Mortola and Feher, 1998) and a similar case is likely for new-born human 382 
infants (Cross et al 1958). The hypothalamus is likely an important site for mediating hypoxic-383 
induced hypometabolism (Mortola, 1993, Mortola and Feher, 1998, Tattersall and Milsom, 384 
2009). This response enhances the new-born’s ability to survive severe and often repeated 385 
hypoxic episodes (Mortola et al 1990), though hypoxia particularly within the first few days 386 
of life in rats can have significant impact on normal transitional adaptations (Massaro et al 387 
1990).  388 
Oxidative Stress 389 
All cells in the body can respond to hypoxia through stabilisation of Hypoxia-inducible Factor 390 
(HIF) and nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) transcription 391 
factors and their nuclear translocation to initiate gene transcription. The pattern, intensity 392 
and duration of the hypoxia influences the balance of HIF-1 and HIF-2 activation as well as the 393 
activation of NFκB (Xu et al., 2015, Prabhakar and Semenza, 2012). In hypoxic conditions, HIF-394 
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1 upregulates enzymes such as membrane bound NADPH oxidase (NOX) and cytosolic 395 
xanthine oxidase (XO) and downregulates HIF-2, increasing reactive oxygen species (ROS) 396 
production and decreasing antioxidant capacity. Increased NOX, XO and production of 397 
inflammatory mediators coupled with decreased antioxidant status contributes to an altered 398 
redox state and possibly oxidative stress. Oxidative stress occurs when the ROS burden 399 
overwhelms the antioxidant capacity required to buffer their harmful effects. Fluctuating 400 
levels of oxygen generate ROS, such as singlet oxygen, superoxide and hydroxyl radicals. ROS 401 
mediates cell signalling, activating inflammatory pathways such as NFκB, but is also capable 402 
of causing direct tissue damage and depletion of antioxidant resources in the short- and long-403 
term. It has been reported that antioxidant capacity increases in preterm infants with 404 
gestational age (Rogers et al., 2000). Dye et al (2017), demonstrated that PD14 rats have 405 
equivalent levels of glutathione, glutathione reductase and glutathione peroxidase to weaned 406 
rats at P21. However, following exposure to ozone PD14 rats have sex-dependent decreased 407 
availability of SOD, glutathione peroxidase and glutathione reductase. As such neonatal rats, 408 
and perhaps preterm infants, may not be able to replenish antioxidants quickly. Interestingly, 409 
work by Prabhakar and colleagues present evidence of neonatal intermittent hypoxia (nIH)-410 
induced SOD2 (superoxide dismutase2) gene methylation which decreases anti-oxidant 411 
reserve, an effect that persists long-term (Dylag et al., 2017, Nanduri and Prabhakar, 2013).  412 
 413 
Animal model of neonatal intermittent hypoxia 414 
Intermittent hypoxia is the most common pattern of hypoxia in preterm infants particularly 415 
those with AOP, whereby the infants have repeated pauses in their breathing often resulting 416 
in episodes of hypoxia and re-oxygenation. Neonatal animal models of IH (nIH) emulate many 417 
aspects of AOP with bradycardia-associated desaturations in blood oxygen (Julien et al., 2008, 418 
Mayer et al., 2015). We have compiled a summary table of studies exploring the effects of nIH 419 
on cardio-respiratory parameters (Table 1) and a figure to illustrate common findings (Figure 420 
2). It is evident that a variety of paradigms have been employed, most studies did not examine 421 
potential sex differences, and only a small proportion of studies controlled for litter size. 422 
Exposure to nIH consistently causes blunted somatic growth in animals, indicative of 423 
conservation of energy (Julien et al., 2008, McDonald et al., 2015, Gozal et al., 2002, Reeves 424 
et al., 2006). Central dysregulation in respiratory control, illustrated by enhanced apnoeic 425 
frequency and blunted autoresuscitation is evident in nIH-exposed rodents (Julien et al., 2008, 426 
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Gozal et al., 2002). In the short-term, nIH also produces a state of autonomic dysregulation 427 
manifest as enhanced sympathetic activity and increased circulating catecholamine 428 
concentrations as a result of stimulated adrenal chromaffin cells (Souvannakitti et al., 2009). 429 
Long-term nIH treated rats exhibit reduced vagal projection to atrial ganglia and enhanced 430 
sympathetic chemoreflexes (Soukhova-O'Hare et al., 2006). Neonatal IH-induced sympathetic 431 
over-activation drives disease states such as hypertension and potentiates activation of the 432 
HPA axis, which we discuss below in respect of the inflammatory response.  433 
 434 
Animal model of neonatal intermittent hyperoxia 435 
Preterm infants commonly treated with supplemental oxygen, coupled with the lack of 436 
continuous monitoring for hyperoxia can inadvertently result in episodes of intermittent 437 
hyperoxia. Few studies have examined the physiological effects of intermittent hyperoxia 438 
exposure in the context of cardiorespiratory function (Table 1). Bavis et al., (2007) report that 439 
intermittent hyperoxia (60% inspired oxygen) did not alter baseline breathing but blunted 440 
hypoxic ventilatory response. In agreement with Bavis et al 2007, Logan et al., (2016) reported 441 
that new-born rats exposed to milder intermittent hyperoxia (30% inspired oxygen) 442 
demonstrated hypo-activation of the carotid body peripheral chemoreceptors during 443 
normoxia and also a blunted hypoxic ventilatory response at P14-15. These studies indicate 444 
divergent phenotypes of intermittent hypoxia compared to intermittent hyperoxia. 445 
 446 
Animal model of neonatal intermittent hypoxia/hyperoxia 447 
Whilst teasing out the impact of neonatal intermittent hypoxia and intermittent hyperoxia is 448 
important mechanistically, we are mindful of the need for more clinically informed models. 449 
The reality is that preterm infants are exposed to intermittent oxygen stress with a 450 
combination of hypoxia, normoxia and inadvertant hyperoxia resulting from therapeutic 451 
oxygen supplementation. Dylag et al., (2017) developed a mixed model exposing neonatal 452 
rats to one week of intermittent hypoxia with a hyperoxic overshoot, reporting long-term 453 
upregulation of NOX in the rat lung and increased airway resistance during early life. Recently 454 
Bavis et al., (2019) carried out an extensive study of the respiratory effects of exposure to 455 
intermittent hypercapnic hypoxia against the background of either normoxia or hyperoxia 456 
compared to control conditions. Bavis et al (2019) report that intermittent hypercapnic 457 
hypoxia along with intermittent hyperoxia (40% FiO2) decreased chemo-afferent activity 458 
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without a change in carotid body size compared to control, however the intermittent 459 
hypercapnic hypoxia treatment with background of normoxia increased chemo-afferent 460 
discharge under basal conditions and increased carotid body size (Table 1). Another study, 461 
using a different pattern of neonatal intermittent hypoxia-hyperoxia, reported long-term 462 
blood-brain-barrier leakiness, which could be indicative of poor vascular development and 463 
oxidative stress (Morken et al., 2013). Capillaries within the rat cortex do not have an adult-464 
like appearance until PD14-21 indicating a period of maturational development in the first 465 
two weeks that render them increasingly vulnerable to ROS. The variable pattern of 466 
oxygenation during early life has been shown to significantly alter redox balance and 467 
respiratory sensitivity. More research is needed to elucidate both the short- and long-term 468 
implications of this stressor and the mechanisms underlying dysfunction. 469 
 470 
Late onset infection 471 
Preterm infants are at increased risk of infectious diseases due to their physiological 472 
immaturity, exposure to adversity and prolonged hospital stays. 70% of late-onset infections 473 
(LOI) occur in preterm infants (Vergnano et al., 2011). In a large cohort of extremely preterm 474 
infants derived from the NICHD network (Stoll et al., 2002, Stoll et al., 2015), those that 475 
survived beyond 3 days post-partum were commonly diagnosed with LOI. Late onset infection 476 
is defined as infection occurring after the first 48-72hours of life (Vergnano et al., 2011).  477 
Although the incidences of LOI have decreased over the years (8% at 28 weeks’ GA and 40% 478 
at 24 weeks’ GA) it remains a significant problem that leads to up to 18% mortality (Stoll et 479 
al., 2015, Tsai et al., 2014, Stoll et al., 2002, Hornik et al., 2012). An infant’s skin, respiratory 480 
tract, gastrointestinal tract, conjunctivae, umbilicus or bloodstream may become colonised. 481 
The mode of infection includes vascular catheters, indwelling lines or nosocomial infection. 482 
The improvements in the incidence of LOI likely reflect improved hand-hygiene, skin care, 483 
human breast milk supplementation, improved practices for catheter insertion and care, and 484 
timely removal of invasive devices. Increased apnoeic events and the need for increased 485 
respiratory support is one of the main presenting symptoms of infection (Fairchild et al., 2016, 486 
Hofstetter et al., 2008). Other symptoms can include brady/tachycardia, poor feeding, change 487 
in skin colour, jaundice, diarrhoea and seizures. Infection in preterm infants diverts energy 488 
away from important neurodevelopmental processes in order to protect the host and fight 489 
infection. LOI is normally confirmed clinically with elevated C-reactive protein in plasma and 490 
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confirmation of bacterial strain with culture. Confirmation of infection with lab culture can 491 
take time, so often infants are administered antibiotics such as vancomycin and/or 492 
gentamicin while awaiting results and symptoms are treated to stabilise the infant. Late onset 493 
hospital acquired infection in preterm babies is an urgent unmet clinical need with the 494 
growing emergence of resistant ‘superbugs’. Both antibiotic overuse and the emergence of 495 
superbugs are endangering the effectiveness of antibiotic treatment (Zea-Vera and Ochoa, 496 
2015, Rasigade et al., 2012). It is important to identify infants most at risk of infection and 497 
implement novel preventative strategies or targeted therapies to avoid long-term morbidity 498 
of this especially vulnerable population.  499 
 500 
Innate immune system 501 
The immune system is a sensory system that interfaces between the environment and host 502 
physiology. The innate immune system is activated by recognition of pattern-associated 503 
molecular patterns (PAMPS e.g. lipopolysaccharide (LPS), peptidoglycan (PGN), lipoteichoic 504 
acid (LTA)) present on the surface of bacteria (Kimbrell et al., 2008, Lotz et al., 2004, Schroder 505 
et al., 2003, Guha and Mackman, 2001) and damage-associated molecular patterns (DAMPS; 506 
Heat shock proteins, HMGB1 and surfactant A) released by the host under stress conditions 507 
such as hypoxia (Klune et al., 2008, Agrawal et al., 2013, Fang et al., 2011). PAMPS and DAMPS 508 
activate pattern recognition receptors (e.g. toll-like receptors (such as transmembrane TLR-509 
1/2, TLR-2/6 and TLR-4), CD-14, NOD-2, peptidoglycan recognition protein and C-reactive 510 
protein). TLR activation can also stimulate the release of soluble TLR’s that can act in negative 511 
feedback fashion (ten Oever et al., 2014). 512 
 513 
Gram-positive bacteria account for nearly half of LOI’s (Vergnano et al., 2011). Organisms 514 
include coagulase-negative Staphylococcus and Staphylococcus aureus. Gram-positive 515 
proteins signal through distinct receptors different to gram-negative bacteria (e.g. E-coli). The 516 
cardiorespiratory effects of acute inflammatory activation by gram-positive bacteria are 517 
largely unknown with the majority of studies focussed on gram-negative endotoxins such as 518 
LPS. LTA and PGN are cell wall components of gram-positive bacteria suggested to activate 519 
TLR-2 leading to increased BBB permeability and activation of the HPA axis (Mayerhofer et 520 
al., 2017). LTA and PGN were reported to act synergistically to mediate multiple organ 521 
dysfunction syndrome in adult rats; shock was associated with a large upregulation of iNOS 522 
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(De Kimpe et al., 1995). TLR-2 involves CD14 modulation and is dependent on MYD88 adapter 523 
protein. Yet LPS, the gram-negative bacterial protein can also potentiate the effect of LTA 524 
(Wray et al., 2001). While previously it was considered that the neonate mounted a weak 525 
immune response, a study by Kollmann et al. (2009) revealed an important insight. The 526 
authors directly compared the immune cell response to both TLR-1/2 and TLR-4 ligands and 527 
found that adult and neonatal cells have qualitatively different responses to activation and 528 
not necessarily less of a response in the neonate when examined as a function of cytokine 529 
production. Similarly, in a study comparing human new-born and adult monocytes derived 530 
from blood samples, the authors describe skewed cytokine profiles in both groups in response 531 
to TLR agonists (Angelone et al., 2006). TLR-2 and TLR-4 are mainly expressed in monocytes; 532 
TLR-2 has a relatively stable expression across development whereas TLR-4 increases with age 533 
(Sadeghi et al 2007). Sex-specific TLR-2 and TLR-4 expression following viral infection in mice 534 
influences survival, higher expression of TLR-2 had a beneficial role in females (Roberts et al., 535 
2012). TLR-2 is altered by both the maternal and neonatal environment (Yu et al., 2018, 536 
Lauener et al., 2002) and nutritional status such as vitamin D (Ojaimi et al., 2013). LPS has 537 
been a useful tool in understanding the role of inflammation on physiological function. LPS 538 
potently activates the innate immune response across development (McDonald et al., 2016, 539 
Rana et al., 2012, Spencer et al., 2010, Fan et al., 2013). The effects of LPS are primarily 540 
mediated through the TLR-4 receptor.  541 
 542 
Activation of immune receptors evokes a plethora of indirect and direct effects on 543 
cardiorespiratory control. Pattern recognition receptors are located on surveiling immune 544 
cells such as macrophages (peripheral nervous system) and microglia (central nervous 545 
system), but also non-immune epithelial and even muscle cells. Boyd et al., (2006) have 546 
demonstrated the presence of TLR-2, TLR-4, TLR-5, and TLR-9 in mouse whole skeletal 547 
muscles, including diaphragm, as well as in differentiated myotubes from C2C12 or primary 548 
cultures. TLR-4 has also been confirmed in human limb muscle and Zong et al. (2013) reported 549 
muscle fatigue mediated through HMGB1 activation of TLR-4. TLR-4 has been reported to 550 
regulate muscle metabolism (Frisard et al., 2010). LPS activation of TLR-4-induced catabolism 551 
was described in murine myotubes (Doyle et al., 2011) and similar findings were reported 552 
using C2C12 cells (Zhang et al., 2017). Li et al. (2018) demonstrated that both TLR-4 knockout 553 
and NF-κB inhibition ameliorated LPS-exacerbated ventilator-induced diaphragm 554 
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dysfunction, due to direct action on the muscle. Effective respiratory skeletal muscle 555 
contraction is necessary to ventilate the lungs; catabolism and muscle fatigue of the 556 
diaphragm mediated through TLR’s would be problematic to an unstable preterm system. 557 
Systemic inflammation communicates via cytokines and neurotransmitters to the autonomic 558 
nervous system (ANS) to regulate homeostasis. Indeed, peripheral inflammation can be 559 
signalled to the brain via interaction with the BBB and production of IL-1β through the 560 
induction of prostaglandin E2 (PGE2), via vagal afferent signalling from the gut/liver/lungs or 561 
transport of cytokines through a leaky BBB (Kiernan et al., 2016, Hofstetter et al., 2007)). 562 
Endotoxins such as LPS can also enter the CNS from the periphery to activate microglia (Fan 563 
et al., 2013). Evidence from clinical and preclinical studies demonstrate that neuro 564 
development and immune function in early life is strongly influenced by gastrointestinal 565 
maturation and colonisation, microglia acting in the CNS and the HPA axis, which will be 566 
discussed below. 567 
 568 
Gastrointestinal maturation and signalling to the brain 569 
As mentioned previously poor nutrition can limit energy necessary for growth and repair, 570 
though nutrition is not just about what we eat/drink. Extremely preterm infants are born with 571 
immature gastrointestinal systems that have yet to be colonised. Increased intestinal 572 
permeability and poor colonisation can alter gut-brain signalling which can impact on 573 
neurodevelopment. Intestinal mucosal permeability or ‘leaky gut’, which can occur in preterm 574 
infants allows bacteria, bacterial toxins, digestive metabolites and small molecules to ‘leak’ 575 
into the bloodstream, this ‘leakiness’ threatens immune activation (Ma et al., 2018, Saleem 576 
et al., 2017). Our intestinal microbiome has an influence on nutrition, intestinal function and 577 
absorption. There is also growing evidence for an important role of the microbiome in overall 578 
health and wellbeing, particularly evident in animal models of disease. A number of recent 579 
papers have highlighted modulating effects of the microbiome on the cardiorespiratory 580 
system (Lucking et al., 2018, O'Connor et al., 2019, Adnan et al., 2017, Ganesh et al., 2018, 581 
Durk et al., 2019, Yang et al., 2017). Clinical studies investigating the role of the microbiota in 582 
preterm infants are growing at pace (Azad et al., 2013, Berrington et al., 2014, Fouhy et al., 583 
2019, Grier et al., 2017, Groer et al., 2014, Xu et al., 2018). A healthy microbiome becomes 584 
established during birth and increases in diversity over the childhood years, as reviewed by 585 
Milani et al. (2017). A diverse and balanced microbiome is beneficial to our digestive system 586 
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as a result of its actions on mucosal barrier function and our neurodevelopment through gut-587 
brain signalling. There is an association between neonatal factors, intestinal microbiota and 588 
intestinal barrier maturation (Ma et al., 2018, Fouhy et al., 2019). A review by Codagnone et 589 
al., (2018) presents the most recent evidence suggesting infant microbiota can be significantly 590 
altered as a result of postnatal stressors. The preterm infant population are at risk of altered 591 
microbiome diversity as a result of caesarean section, higher rates of formula feeding, 592 
invasive procedures, oxygen dysregulation and pre- and post-natal antibiotic exposure 593 
(Pammi et al., 2017, Dahl et al., 2018, Yee et al., 2019, Penders et al., 2006, Azad et al., 2013, 594 
Lucking et al., 2018). Dysbiosis in the immature infant gut is associated with pathogenesis of 595 
LOI’s and inflammatory processes such as necrotising enterocolitis (NEC) (Berrington et al., 596 
2014, Stewart et al., 2017). Alteration in circulating short-chain fatty acids, which is likely a 597 
result of poor colonisation, is just one consequence of prematurity. Importantly short-chain 598 
fatty acids have been demonstrated to play a role in the maturation of microglia, immune 599 
cells of the CNS (Erny et al., 2015). Healthy preterm infants born before 33 weeks and breast-600 
fed have significantly lower short-chain fatty acids compared to infants born between 33 and 601 
37 weeks of gestational age (Favre et al., 2002). Short-chain fatty acids were also found to be 602 
lower in formula-fed preterm infants. Short-chain fatty acids such as propionate cross the 603 
mucosal barrier and bind to FFAR3 expressed on sympathetic ganglia and enteric nerves while 604 
butyrate binds to GPR109A expressed on microglia and potentially on enteric glial cells (Nohr 605 
et al., 2013) may have an important role in gut-brain signalling. The use of probiotics as a 606 
therapeutic strategy in the NICU is limited based on current evidence (Costeloe et al., 2016), 607 
however meta-analysis data indicate that probiotics are effective at decreasing mortality, NEC 608 
and LOI (Athalye-Jape and Patole, 2019). In extremely preterm infants, parenteral nutrition is 609 
often required to prevent rapid essential fatty-acid deficits (Koletzko et al., 2005, van den 610 
Akker et al., 2010). In Ireland, lipid 1g/kg/day is currently set out in the Health Services 611 
Executive guidelines for preterm parenteral nutrition increasing to 4g/kg/day over the first 4 612 
days (HSE, 2018) these guidelines in line with those of The European Society for Paediatric 613 
Gastroenterology Hepatology and Nutrition (Lapillonne et al., 2018). These lipid formulations 614 
do not include common short-chain fatty acids such as propionate and butyrate and deficits 615 
may have a significant impact on neurodevelopment in the preterm infant.  616 
There is growing interest in the potential role of the gut-brain axis in modulating 617 
cardiorespiratory physiology (Lucking et al., 2018, O'Connor et al., 2019, Adnan et al., 2017, 618 
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Ganesh et al., 2018, Durk et al., 2019, Yang et al., 2017). In a model of gestational stress 619 
employed using intermittent restraint and bright light exposure, significant correlations were 620 
observed in adult offspring between altered gut microbiota composition and respiratory 621 
frequency, and gestational stress also increased responsiveness of the large intestine to 622 
sympathetic drive (Golubeva et al., 2015). Lower systolic blood pressure and pulse pressure, 623 
blunted ventilatory responsiveness to hypercapnia and disrupted brainstem neurochemistry 624 
was observed in rats following chronic broad-spectrum antibiotic intervention (O'Connor et 625 
al., 2019). A recent study by Giri et al., (2019) reported that mice raised in a germ-free 626 
environment with the absence of a microbiome and consequently short-chain fatty acids had 627 
an impaired adrenal catecholamine response to hypoglycaemia. Dysbiosis may influence 628 
excitation of cells in the nTS, a central processing site in the brain for autonomic function. 629 
Autonomic ganglia such as nodose ganglia express TLR’s that recognise PAMPs are also likely 630 
to influence the bi-directional communication along the gut- brain axis via the vagus nerve 631 
(Hosoi et al., 2005). IL-1β has been shown to cause a vagal-dependent decrease in hypoxic 632 
ventilatory response in neonatal rat pups (Balan et al., 2011).  These observations support a 633 
modulatory role for the microbiome and gastrointestinal integrity on immune activation and 634 
cardiorespiratory control. Future studies focusing on gut-brain signalling and its influence on 635 
autonomic control in neonatal animal models and preterm infants are needed. 636 
 637 
Microglia in the CNS 638 
Microglia are the prevailing immune cells of the CNS. They are present from early in 639 
embryonic development and exhibit a developmental, regional specific and sex-dependent 640 
profile (regulated both hormonally and genetically) (Hanamsagar and Bilbo, 2016, Schwarz 641 
and Bilbo, 2012). Microglia have important roles in development, including synaptogenesis, 642 
apoptosis, synaptic pruning, neuronal progenitor cell switching which are important for 643 
refining neural networks. Microglia have been a recent focus of research and could be 644 
important players in the sex-specific modulation of cardiorespiratory networks. Microglia 645 
densely populate certain regions of the brain such as hippocampus an important part of the 646 
HPA axis, but are also expressed throughout the brainstem and there is evidence to suggest 647 
that they modulate cardiorespiratory function (MacFarlane et al., 2016, Baldy et al., 2016). 648 
MacFarlane et al., (2016) reported that inhibition of microglia with minocycline, during 649 
sustained hypoxia, prevents decrease of 5-HT in the nTS, an important nucleus for cardio-650 
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respiratory and autonomic regulation. This suggests a negative impact of glia in 651 
neuromodulation during hypoxic stress. Activation of macrophages or microglia stimulate 652 
phagocytosis and/or release of pro- (e.g. IL-1β, IL-6 TNF-α) and anti-inflammatory cytokines 653 
(e.g. IL-10) to produce a measured response. Several immune cytokines including IL-1β, IL-6, 654 
PGE2 and LPS itself interact within hypothalamic and medullary regions such as the 655 
paraventricular nucleus (PVN), nucleus of the solitary tract (nTS) and rostro-ventrolateral 656 
medulla (RVLM). Fractalkine is a chemokine primarily released by neurons in the brain that 657 
binds to its receptor CX3R1 expressed exclusively on microglia, inducing pro-inflammatory 658 
cytokine release. Fractalkine has been reported to cause tachycardia and hypotension when 659 
microinjected into the PVN (Ruchaya et al., 2014). Activation of the immune system in early 660 
life has been associated with long-lasting psychological dysregulation such as anxiety but also 661 
altered immune responsiveness (Boissé et al., 2004, Spencer et al., 2006a, Spencer et al., 662 
2005). Sex differences have been reported in both the expression and state of activation of 663 
glia. For example, adult females at rest have more primed and ramified microglia in mPFC 664 
compared to males (Bollinger et al., 2016). Glia express a range of steroid hormone receptors 665 
including both oestrogen and progesterone receptors, that could be important in the 666 
determination of sex-specific activation as well as glucocorticoid receptors that respond to 667 
stress  (Domercq et al., 2013, Madalena and Lerch, 2017, Sierra et al., 2008). In light of the 668 
increased collective understanding of glia, the brain is no longer considered ‘immune 669 
privileged’ as was once previously thought. Microglia present in the CNS can be activated by 670 
common postnatal stressors such as hypoxia, carry out neuromodulatory role during 671 
development and are a possible source of sex differences. Further studies are required to 672 
reveal the extent microglia contribute to cardiorespiratory control in preterm and neonatal 673 
animals. 674 
 675 
Immune-HPA axis 676 
Cortisol has an important developmental role in human infants particularly in the maturation 677 
of the lungs and regulation of blood pressure (Bolt et al., 2001, Ng et al., 2004). Adrenal 678 
hyporesponsiveness and low cortisol were associated with hypotension in preterm infants 679 
during the first days of life (Ng et al., 2004). Metabolic stressors common in preterm infants 680 
including hypoxia and infection can also stimulate the HPA axis and the sympathetic adrenal-681 
medullary axis to release glucocorticoids and catecholamines (Karrow, 2006, Zacharowski et 682 
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al., 2006, Seidler and Slotkin, 1985, Snyder et al., 2018). Cortisol is an agonist for 683 
glucocorticoid receptors which are widely expressed in liver, muscle, lung, adipose tissue and 684 
immune cells. There is also evidence to show that glucocorticoids can also be produced locally 685 
in organs such as lymph, brain and skin (Taves et al., 2011). Glucocorticoid receptors are 686 
present in the cytosol or are expressed on the cell membrane (Strehl et al., 2011). 687 
Glucocorticoid receptors have a number of splice variants and a variety of gene binding sites 688 
that may control cell-specific effects (Oakley and Cidlowski, 2013, John et al., 2011, Biddie et 689 
al., 2011). Glucocorticoid receptors in the brain mediate negative feedback to inhibit further 690 
activation of the HPA axis but also decrease CBG production in the liver. The role of 691 
glucocorticoids in innate immune response is affected by modulation of gene transcription 692 
mediated through glucocorticoid receptor activation. Glucocorticoid receptor activation has 693 
many beneficial actions with the capacity to inhibit pro-inflammatory cytokines, upregulate 694 
anti-inflammatory cytokines and alter mitochondrial respiration to reduce ROS (Kasahara et 695 
al., 2015, Long et al., 2005, Gerö and Szabo, 2016, Kasahara and Inoue, 2015). Glucocorticoids 696 
and glucocorticoid receptors exist in conjunction with accessory proteins such as hsp90 697 
hsp70, and the FKBP52 (Pratt et al., 2006, Ratajczak et al., 2003) and have significant cross-698 
talk with transcription factors NF-κB, AP-1, PPARα to modulate inflammation. Glucocorticoids 699 
however can also sensitise the initial inflammatory response through upregulation of NOD-700 
like receptors that are part of the inflammasome (Busillo et al., 2011). Further evidence also 701 
suggests that glucocorticoids can increase sympathetic release of noradrenaline and activate 702 
β-adrenergic receptors associated with increased IL-1β and microglial priming, these may 703 
contribute to enhanced inflammatory response. The control of inflammation and sympathetic 704 
tone by the HPA axis is an important contributor to cardio-respiratory function. 705 
 706 
Inflammation and Hypoxia in early life  707 
Animal models of early-life infection have revealed important insights into immune function. 708 
Boisse et al., (2004) illustrate long lasting effects of neonatal immune challenge such that P14 709 
Sprague Dawley rat pups treated with LPS exhibit a blunted fever response to subsequent LPS 710 
in adulthood. A similar study was carried out using viral immune challenges during early life 711 
and again at adulthood. Animals administered again at adulthood exhibited a blunted fever, 712 
though interestingly if the two stimuli were different no long-term effect on the immune 713 
system was observed (Ellis et al., 2006). Further studies identified a critical window for early 714 
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life infection such that days P14 and P21 attenuated adult fever in response to LPS, but 715 
injections given on days P7 and P28 did not, however later time points were associated with 716 
changes in behaviour (Spencer et al., 2006b). Spencer et al., (2007) also demonstrated that 717 
LPS administration in P14 animals had an exacerbated response to a colitis-inducing agent, 718 
2,4,6-trinitrobenzenesulfonic acid that was associated with augmented immune 719 
responsiveness. Sex-dependent responses to immune challenge are also reported. Male rats 720 
challenged with LPS at P4 had greater mortality compared to females, and those males that 721 
survived the LPS challenge had lower weight gain at juvenile age (Hocker et al., 2019). Females 722 
expressed lower concentrations of cyclooxygenase compared to males during blunted febrile 723 
response in adulthood, perhaps indicating differential regulation despite a similar phenotype 724 
(Spencer et al., 2006a, Kentner et al., 2010). These studies indicate that the nature of the 725 
stimulus as well as the developmental period and sex of the host have important influences 726 
on the long-term inflammatory responses. Martin (2009) posits that the immune system is 727 
primarily upregulated during acute stress but in the face of chronic stress the immune system 728 
is downregulated for energy conservation. The HPA axis can be epigenetically modified by 729 
stress at multiple levels including DNA methylation of glucocorticoid receptors at the level of 730 
the hippocampus (Weaver et al., 2004), and hypomethylation of CpG residues of the AVP gene 731 
within the hypothalamus (Murgatroyd, 2014, Murgatroyd et al., 2009) with knock on effects 732 
on the inflammatory process. Exposure to CIH in adult rats has been reported to activate and 733 
sensitise the HPA axis to future stressors (Mifflin et al 2008). Exposure to nIH has been shown 734 
to increase plasma ACTH and corticosterone in rats at postnatal day 2, 8, 10, 12 and 14 along 735 
with hyperglycaemia (Chintamaneni et al 2013). Sex-dependent responses are also evident 736 
when nLPS was coupled with an adult restraint stress in Wistar rats, which caused prolonged 737 
peak corticosterone secretion in both sexes compared to control groups that did not receive 738 
nLPS; only treated males exhibited elevated TNFα concentrations in the hippocampus (Walker 739 
et al., 2010). Importantly, this study by Walker et al (2010) illustrates that physiological early 740 
life stress can interact with psychogenic stressors later in life to alter immune function.  741 
Physiological stress such as early life oxygen dysregulation, inflammation and ROS generation 742 
could alter response to early life infection in a time- and sex-dependent manner. 743 
 744 
Hypoxia and inflammation are inextricable linked (Koeppen et al., 2011, Nizet and Johnson, 745 
2009, Rius et al., 2008, van Uden et al., 2008, Crifo and Taylor, 2016). There are many redox-746 
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sensitive pathways, but one of the most studied in recent years is the NFκB-dependent 747 
pathway, which plays an important role in the innate immune response. Although tightly 748 
cross-linked to the HIF-1 pathway, NFκB can also be activated directly by hypoxia when 749 
oxygen sensitive prolyl hydroxylases (PHD) are disinhibited by Iκ β kinase (IKK-β) paving the 750 
way for NFκB transcription of inflammatory cytokines. Inflammation and hypoxia stabilise HIF-751 
1 via distinct signalling pathways (Jantsch et al., 2011).  752 
 753 
The pro-inflammatory nature of nIH has been demonstrated by increased serum cytokines 754 
and cytokine expression in the cerebellum (Darnall et al., 2017). In reverse, when LPS is 755 
administered at P2, rats exhibited spontaneous bouts of IH, attenuated hypoxic ventilatory 756 
response and blunted carotid body responsiveness to hypoxia that was associated with 757 
elevated dopamine levels and increased mRNA for inflammatory cytokines (Master et al., 758 
2016). This suggests that early life infection can alter sensory input to the central respiratory 759 
network destabilising breathing. Recently, Hocker et al. (2019) revealed that one bout of LPS 760 
at P4 caused long-lasting impairments in the respiratory motor plasticity system. Long term 761 
facilitation of respiratory motor output in the adult was impaired via the serotonin dependent 762 
pathway (Q) but was reversible by anti-inflammatory drug ketoprofen administered during 763 
adulthood. The adenosine dependent pathway (S) was also impaired but could be stimulated 764 
via adenosine agonists (Hocker et al., 2019). Motor plasticity is likely an important adaptive 765 
response of the respiratory system in the face of physiological stressors such as hypoxia. The 766 
impact of specific cytokines such as IL1β on the respiratory system has been demonstrated 767 
by Hofstetter et al. (2007) in P9 mice pups causing apnoea, irregular breathing patterns and 768 
autoresuscitation failure through the activation of Prostaglandin E2 acting on EP3R receptors 769 
in respiratory centres. The proposed mechanism of action is via cytokine interaction with the 770 
blood brain barrier. However, LPS administered to P7 rat pups, 3 hours prior to hypoxia 771 
exposure did not alter hypoxic ventilatory response, but blunted hypoxic induced tachycardia 772 
(McDonald et al., 2016). This suggests that there may be critical windows wherein interactions 773 
between stimuli can differ. There is evidence to suggest that hypoxia and LPS together 774 
exacerbate the inflammatory response with crosstalk between HIF and TLR-4 signalling. One-775 
week old rats treated with LPS, 4 hours prior to hypoxic-ischaemic injury exhibited significant 776 
cerebral infarction that was associated with an increase in both CD14 and TLR-4 mRNA 777 
expression (Eklind et al., 2001). Hypoxia (6 hours) and LPS administered together in adult rats 778 
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exacerbated acute lung injury by increasing cytokine production in a TLR-4-dependent 779 
manner, suggesting cross-talk between TLR-4 and the HIF-1α pathway (Wu et al., 2018). In 780 
support of this finding, Yao et al., (2013) found that LPS exposure in cultured microglia cells 781 
from P0 Wistar rats exhibited upregulation of TLR-4 receptor and gene expression of IL-1β 782 
was enhanced by hypoxia. Similar findings were observed in cultured human periodontal 783 
ligament cells (Jian et al., 2014) and murine dendritic cells prepared from bone marrow 784 
precursors (Jantsch et al., 2011). A study by Thompson et al., (2017) provided evidence that 785 
hypoxia and inflammation together potentiate sickness behaviours and increase mortality, 786 
however when hypoxia preconditioning was performed (7 days at 10% O2), mice exhibited 787 
marked protection from S. aureus infection. Therefore, it remains unclear what the impact of 788 
early life hypoxia is on subsequent infections. It is feasible that similar to the blunting of the 789 
inflammatory response evident in response to a second immune challenge later in life (Boisse 790 
et al., 2004, Spencer et al., 2006a), hypoxia can also blunt the innate immune response in the 791 
long-term. Polke et al. (2017) reported that in cultured human bronchial epithelial cells, 792 
hypoxia and HIF-1α suppress the release of inflammatory cytokines. The influence of hypoxia 793 
on subsequent immune activation is likely dependent on pattern, intensity and timing and 794 
may be sex-dependent. A study by Kuhlicke et al., (2007) indicated a role for HIF-1-dependent 795 
upregulation of TLR-2 and TLR-6 in murine dendritic cells exposed to hypoxia, which would 796 
have important implications if subsequently faced with a gram-positive bacterial challenge. 797 
 798 
Summary 799 
The ontogeny of our integrated physiological network begins during embryogenesis and 800 
becomes fine-tuned throughout gestational and neonatal development. Maternal 801 
psychogenic stress, smoking, infection, and hypertension as well as multiple offspring, 802 
placental insufficiency and fetal intra-uterine growth restriction can lead to premature 803 
delivery and a sequel of post-natal stressors that can tamper with the programmed 804 
development of the integrated physiological network in the short- and long-term. Current 805 
translational and clinical research aims to understand the physiology of the preterm infant 806 
and impact of the environment on these vulnerable babies to minimise the risk to preterm 807 
infants and develop effective therapeutic strategies to enable infants to thrive.  808 
 809 
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Hypoxia in the preterm has long been identified as a major source of dysfunction that has 810 
been primarily managed with oxygen therapy through various modes of delivery. In neonatal 811 
animal models of oxygen dysregulation, somatic growth and cardiorespiratory control are 812 
altered. Both hypoxia, hyperoxia and variable patterns of intermittent oxygenation have been 813 
demonstrated to increase the release of ROS. ROS contributes to redox modulation of genes 814 
and cell pathways as well as cell damage and the activation of immune signalling cascades. 815 
Infection is also a major source of morbidity and mortality within the preterm populations 816 
that often occurs in babies with antecedent or on-going oxygen dysregulation. In the context 817 
of oxygen dysregulation and subsequent infection, the interplay between oxidative stress and 818 
inflammation in male and female preterm babies remains poorly understood. 819 
 820 
Important differences between sexes are increasingly being highlighted prompting new 821 
investigations of the physiology underlying these differences and sex-specific therapies to 822 
better treat male and female babies. Intrinsic differences in expression and activation of cells 823 
such as microglia, neuronal pathways and neurochemistry are increasingly apparent between 824 
sexes in terms of responses to physiological stressors, as well as X chromosomal-linked and 825 
hormonal driven changes. Epidemiological evidence suggests that males are more vulnerable 826 
to acute stressors and poorer respiratory outcomes, whereas females are at increased risk of 827 
chronic immune conditions  828 
 829 
The integrated autonomic output of the cardiorespiratory system will be influenced by direct 830 
effects of hypoxia, as well as modulatory influences along the gut-brain axis from the 831 
microbiome/immune system, central modulation by activated glia cells and the prevailing 832 
hormonal concentrations determined by the activation of the HPA axis. This short review 833 
highlights current knowledge on early life oxygen dysregulation, inflammation and 834 
cardiorespiratory performance. Much work remains to explain the mechanisms underlying 835 
chronic disturbances in males and females born prematurely. Continued translational and 836 
clinical research can ensure those born early receive the best support that limits harm and 837 
maximises quality of life. 838 
 839 
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Paradigm Nadir FiO2 
Peak 
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Outcome measured Significance 




12 Intermittent Hypoxia 
 
21% O2 to 5% O2 in 100 s and 
then returned to 21% O2 in 140 s, 
followed by normoxia during 6 
min. This 10-min cycle was 
repeated six times, followed by 1 
h of normoxia and repeated 24 h 
a day during 10 consecutive days 
















Julien et al., 2010 Rat, SD P1-P10 Males only 12 Intermittent Hypoxia 
 
21% O2 to 5% O2 in 100 s and 
then returned to 21% O2 in 140 s, 
followed by normoxia during 6 
min. This 10-min cycle was 
repeated six times, followed by 1 
h of normoxia and repeated 24 h 
a day during 10 consecutive days 
5% 21% 3-4 Months Body Mass 
WBP 
fR (B) 
V�E (B)  















Julien et al., 2011 Rat, SD P3-P12 Males only 12 Intermittent Hypoxia 
 
21% O2 to 5% O2 in 100 s and 
then returned to 21% O2 in 140 s, 
followed by normoxia during 6 
min. This 10-min cycle was 
5% 21% P12 Body Mass nIH + water 
WBP 
fR (B) nIH + water 






repeated six times, followed by 1 
h of normoxia and repeated 12 h 
a day during 10 consecutive days 
V�E (B) nIH + water 
V�E (B) nIH + caffeine 
V�E/ V�O2   nIH + water 
V�E/ V�O2  nIH + caffeine 
Apneoas nIH + water 







Mayer et al., 2015 Rat, L P5-P15 Male - P0-P5 normoxia followed by 
Intermittent Hypoxia 
Every 5min,8h/day for 10days 
 
Pre-treated P0-P5 sustained 
Hypoxia (11%) followed by 
Intermittent Hypoxia 
Every 5min,8h/day for 10days 
 
5% 21% P16 Petrosal activity (B) nIH 
Petrosal activity (B) SH + 
nIH 
Petrosal activity (H) nIH 
Petrosal activity (H) SH 
+  nIH 
nTS activity nIH 









Peng et al., 2004 Rat, SD P0 undefined - Intermittent Hypoxia  
 
nadir of 5% O2 during hypoxia 
within 68–75 s and 21% O2 
during normoxia within 70–85 s. 
Nine episodes of IH per hour for 
16 h. 














McDonald et al., 
2015 
Rat, W P0-P22 Male & 
Female 
groups 
- Intermittent Hypoxia  
 
90 s of hypoxia (5% O2 at the 
nadir) followed by 210 s of 








normoxia (21% O2) i.e., 12 cycles 
per hour 
Resp. Muscle Function 
P22 




McDonald et al., 
2016 
Rat, W P0-P22 Male & 
Female 
groups 
- Intermittent Hypoxia –nIH 
 
90 s of hypoxia (5% O2 at the 
nadir) followed by 210 s of 
normoxia (21% O2) i.e., 12 cycles 
per hour for 21 days 
 
Intermittent Hypoxia –nIH + aIH 
 
90 s of hypoxia (5% O2 at the 
nadir) followed by 210 s of 
normoxia (21% O2) i.e., 12 cycles 
per hour for 21 days 
Repeat exposure for 21 days at 
13 weeks 
5% 21% Adult IH 
13-16 
weeks 
Body Mass nIH 
  





Resp. Muscle Function 
nIH  
Resp. Muscle Function 









Gozal et al., 2002 Rat, SD P0-P5 undefined - Intermittent Hypoxia 
 
10% O2 (90 s) alternating with 
21% O2 (90 s), 12 h/day 






Reeves et al., 
2006a 
Rat, SD P1- P30 Male 8 Intermittent Hypoxia 
every 90 s for the 12-h/day for 30 
days 










Reeves et al., 
2006b 
Rat, SD P0-P5,  
-P10,  
-P15,  
Male 8 Intermittent Hypoxia 
every 90 s for the 12-h/day for 30 
days 











V�E/ V�CO2   (B) 
↑P10, P15 &P30  
↑P30 
Soukhova-O’Hare 
et al., 2006a 
Rat, SD P1-P30 Male -  Intermittent Hypoxia 
 
8% O2 (90 s) alternating with 
21% O2 (90 s), 12 h/day and 21% 
O2 during the remaining 12 h. 









et al., 2006b 
Rat, SD P1-P30 Male - Intermittent Hypoxia 
 
 8% O2 (90 s) alternating with 
21% O2 (90 s), 12 h/day and 21% 
O2 during the remaining 12 h. 
8% 21% 5-7 months Body Mass 
MAP 
Renal sympathetic nerve 
activity (B) 









et al., 2008 
Rat, SHR P4-P30 Male - Intermittent Hypoxia 
 
 10% O2 (90 s) alternating with 
21% O2 (90 s), 12 h/day and 21% 
O2 during the remaining 12 h. 











Rat, SD P0-P5 undefined - Intermittent Hypoxia 
15-s 5% O2 followed by 5-min 
21% O2; 8 h/day) for 5 days 









Rat, SD P0-P5 undefined - Intermittent Hypoxia 
15-s 5% O2 followed by 5-min 
21% O2; 8 h/day) for 5 days 
5% 21% P5 Nicotine evoked 
Catecholamines 
 
nAChR gene expression 





Chu et al., 2015 Mouse, 
C57BL/6
J  
P0-P28 Male 6 Intermittent hypoxia  
 
Alternating cycles of 8% and 21% 
FiO2 with 120-s cycle duration 
for 6 h per day 







Vasodilation to Ach 
ACE 
ROS 











Pawar et al., 2008 Rat, SD P1 
P1-P3 
-P10 
undefined - Intermittent hypoxia  
15s 5% O2 followed by 5-min 21% 
O2, 9 cycles per hour, for 8 h/day 




Carotid Body Hypoxic 
response 
Carotid Body LTF 




Nanduri et al., 
2012 
Rat, SD P1-P10 Male and 
female 
grouped 
- Intermittent Hypoxia 
15-s 5% O2 followed by 5-min 
21% O2; 9 cycles per hour, 8 
h/day, for 10 days 
5% 21% P40-50 Body Mass 
Carotid Body Activity 
MDA 
Catecholamine secretion 
























Darnall et al., 2017 Rat, SD P2-12 Male and 
female 
pooled 
10 Intermittent Hypoxia  
 
6 decreases in chamber oxygen 
concentration per hour (3 min, 
allowing ~ 7 min of room air 
exposure between 
Events) alternating with an hour 
of normoxia 
 





























- Intermittent Hypoxia 
2min 6-7.5% O2 followed by 3 
min 21% O2, 8 hours per day 
6% 21% P30 Body Mass 
Na/H exchanger 1 












P2-P30 Male and 
females 
pooled 
8 Intermittent Hypoxia 
4 min 11% O2, 4 min 21% O2, 















Kanaan et al., 2006 Mouse, 
CD-1 
P2- P16 
    - P30 
undefined - Intermittent Hypoxia 
4 min 11% O2, 4 min 21% O2, 











Cai et al., 2011 Mouse, 
C57BL/6 






20.9% O2/8.0% O2 alternation 
cycles (and in some cases, 
20.9% O2/5.7% O2 alternation 
cycles) lasting 120 s (i.e. 






















, cerebellum  







Cai et al 2012 C57BL/6 P2 to 
P10 






20.9% O2/8.0% O2 alternating 
cycles lasting 120 s (i.e. 
30 episodes per hour) for 6 h a 
day 
 
20.9% O2/5.7% O2 alternation 
cycles lasting 120 s (i.e. 































- Intermittent Hypoxia 
21% O2 for 4 min and 11% O2 for 














↑ P9, P16 
→P30 
↑375 & ↓440 
genes P9 
↑440 & ↓795 
genes P16 
↑150 & ↓68 
genes P30 
Pozo et al., 2012 Rat, SD P1-P7 undefined 10 Intermittent Hypoxia dispersed 
(nIHd) 
5% 21% 4-8 Weeks Body Mass nIHd ↓  
 52 
dispersed hypoxia exposures 
consisted of 45 s of hypoxia 
(nadir of 5% O2; FiO2 60%) 
followed by 4 min and 15 s of 
21% O2 continuously over 8 h for 
7 days 
 
Intermittent Hypoxia clustered 
(nIHc) 
45 s of hypoxia (nadir of 5% O2) 
followed by 90 s of 21% O2. These 
135 s duration cycles occurred 
over three periods of 72 min 
duration per day interspersed 
with 2.2 h of RA exposure for 7 
days 










Mayer et al., 2013 Rat, L P5-P15 Male - P0-P5 normoxia followed by 
Intermittent Hypoxia 
Every 5min, 8h/day for 10days 
 
Pre-treated P0-P5 Hypoxia (11%) 
followed by Intermittent Hypoxia 
Every 5min, 8h/day for 10days 
 
5% 21% P16 Body Mass nIH 
Body Mass SH + nIH 
WBP 
FR (B) nIH 
FR (B) SH + nIH 
V�E (B) nIH 
V�E (B) SH + nIH 
V�E/ V�O2   nIH 
V�E/ V�O2   SH + nIH  
 
HVR nIH 




















8  Intermittent Hypoxia/ 
Hypercapnia (8%)  
 
11% 21% P16 Body Mass 
Haematocrit 





4 min 11% O2/8% CO2, 4 min 21% 







Dylag et al., 2017 Mouse, 
C57BL/6  
P0—P7 undefined - Intermittent Hypoxia (IH) 
10% O2 (1 min) followed by 
return to normoxia on 10-min 
repeating cycles 24 h/d from 
birth to P7. 
 
Intermittent Hyperoxia (IHyper) 
Transient 50% O2 followed by 
return to normoxia on 10-min 
repeating cycles 24 h/d from 
birth to P7. 
 
Intermittent Hypoxia and 
Intermittent Hyperoxia 
(IHHyper) 
10% O2 (1 min) followed by a 
transient exposure to 50% FIO2, 
on 10-min repeating cycles 




























SOD 1 IHyper 




















- Intermittent hyperoxia 
5 cycles per hour, 24hr per day 
 
Intermittent hyperoxia 















Body Mass IHyper30 
Body Mass IHyper 60 
HVR IHyper30 
HVR IHyper 60 
Chemo-afferent activity 
(B) IHyper 30 
Chemo-afferent activity 
(B) IHyper 60 
↑ P4, P6-7 








(H) IHyper 30 
Chemo-afferent activity 





Bavis et al., 2007 Rat, SD P0-P14 Male and 
female or 
male only 
 Intermittent hypercapnia (ICO2 
)(<0.4 and 7.5% at 1-h intervals 
24 h per day) 
 
Hyperoxia with intermittent 
hypercapnia (HyperICO2) (<0.4 
and 7.5% at 1-h intervals 24 h 
per day) 
 
Intermittent hyperoxia (IHyper) 
Oxygen switched 1-h intervals 









6-10 weeks Body Mass  
WBP 
V�E (B) 
fR (B)  




fR (H)  
 















HyperICO2                 
↓ IHyper 





- Intermittent hypoxia (10%) 
/Hypercapnia (5%) with 
background normoxia 
 
Intermittent Hypoxia (10%) 
/Hypercapnia (6%)/hyperoxia 
(30%) with background 
normoxia (21%) 
 
Intermittent Hypoxia (10%) 
/Hypercapnia (5%) with 






























→a, b, c, d 
↑a,b →c,d 
↑a →b, c ↓d 
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Intermittent Hypoxia (10%) 
/Hypercapnia (6%)/ hyperoxia 









→a, b →c ↓d 
↑a, →b, c, d 
Morken et al., 2013 Rat, SD P0-P14 undefined - Intermittent Hypoxia Hyperoxia 
 
Hyperoxia (50% O2) 
interrupted by three consecutive 
two-minute episodes of hypoxia 
(12% O2) every sixth hour. 




mean, axial and radial 
diffusivity 
→P14 ↑ P28 
 




A summary of publications examining the effects of intermittent hypoxia, intermittent 
hyperoxia and/or intermittent hypoxia and hyperoxia on cardio-respiratory function. The 
table outlines the strain, age and sex used in the study and a description of the experimental 
paradigm indicating both the peak and nadir % FiO2 experienced by the animals in the study. 
The table also indicates the major cardio-respiratory related findings from each study 




















Resting V�E – unaltered 
↑HVR 
↑Apnoeas  
↓ Airway dilator muscle 
force 
  























Preterm infants fail to reach the maturity of a term infant, which hinders their transition to 
life outside of the uterus. An efficient cardio-respiratory system is vital to sustain life. As 
illustrated above, this system is often compromised in preterm infants and those that are 
born earliest have the poorest outcomes, both in the short- and long-term. 
 
Figure 2 
Animal models of neonatal intermittent hypoxia have revealed significant dysfunction at 
several key sites that can alter cardiorespiratory physiology. The illustration captures the 
wide-ranging impact of oxygen dysregulation during early life. If translated to the preterm 
infant, these phenotypes would contribute significantly to the sequel of short- and long-term 
morbidity. 
 
